Search by Drug Name or NDC
NDC 43749-0470-01 Avedana Hemorrhoidal 144; 150; 25; 10 mg/g; mg/g; mg/g; mg/g Details
Avedana Hemorrhoidal 144; 150; 25; 10 mg/g; mg/g; mg/g; mg/g
Avedana Hemorrhoidal is a TOPICAL CREAM in the HUMAN OTC DRUG category. It is labeled and distributed by Unipack LLC. The primary component is GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE.
Product Information
NDC | 43749-0470 |
---|---|
Product ID | 43749-470_f28f8618-610b-7440-e053-2995a90a1f2b |
Associated GPIs | 89992004743720 |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Avedana Hemorrhoidal |
Proprietary Name Suffix | Maximum Strength |
Non-Proprietary Name | Hemorrhoidal |
Product Type | HUMAN OTC DRUG |
Dosage Form | CREAM |
Route | TOPICAL |
Active Ingredient Strength | 144; 150; 25; 10 |
Active Ingredient Units | mg/g; mg/g; mg/g; mg/g |
Substance Name | GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE |
Labeler Name | Unipack LLC |
Pharmaceutical Class | Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part346 |
Listing Certified Through | 2024-12-31 |
Package
NDC 43749-0470-01 (43749047001)
NDC Package Code | 43749-470-01 |
---|---|
Billing NDC | 43749047001 |
Package | 1 TUBE in 1 CARTON (43749-470-01) / 25.5 g in 1 TUBE (43749-470-03) |
Marketing Start Date | 2020-11-04 |
NDC Exclude Flag | N |
Pricing Information | N/A |